Re: More about Repel-CV9R) adhesion barrier

From: Jenny (kummer_jennifer1@hotmail.com)
Tue Mar 17 12:15:34 2009


It sounds like they are working on something for abdominal adhesions...

http://www.synthemed.com/gynecologic_surgery.html

Product Development: Gynecologic SurgeryUsing our bioresorbable polymer technology to reduce post-operative gynecologic adhesions

For many women, one gynecologic surgery can turn into a painful and expensive cycle of ongoing surgical procedures. An initial surgery to preserve or reestablish fertility can lead to post-operative adhesions, requiring further surgical intervention to relieve chronic symptoms such as pain, infertility and small bowel obstruction.

Each year alone, nearly 500,000 adhesiolysis procedures are performed in the United States solely to remove adhesions in the abdominal cavity that are the cause of these post-operative symptoms.

Products for open and laparoscopic surgical procedures Since approximately two-thirds of all gynecologic surgical procedures in the United States are performed laparoscopically (less invasively), the preferred anti-adhesion product must be both safe and effective as well as easily applied in both open and less-invasive procedures.

> Return to top.

RESOLVE™ Adhesion Barrier Instillate

To address the market opportunity for a product intended to reduce post-operative adhesion formation in gynecologic surgery, SyntheMed is developing viscous solutions (instillates) derived from our proprietary bioresorbable polymer technology. Our objective is to provide surgeons with products that are effective in reducing the extent and severity of adhesions and are easy to use in both open and less-invasive surgical procedures.

Viscous solutions would be used as an instillate that is poured (in open procedures) or injected (in laparoscopic procedures) into the peritoneal cavity at the conclusion of the procedure. It is anticipated that coating and lubricating the traumatized tissue surfaces would protect the organs from adhesion formation. The viscous solutions would continue to recoat these tissue surfaces as the patient ambulates during the immediate post-operative recovery phase.

REPEL™ Adhesion Barrier

Products derived from our bioresorbable polymer film technology can be used to provide site specific protection against post-operative adhesion formation between apposing tissue surfaces. For example, the formation of adhesions between the uterus and bladder after cesarean section deliveries can increase the risk of injury to the mother and fetus as well as extend the critical time of delivery during subsequent cesarean section procedures.

Maybe hope is around the corner!!! Thank God!

At Tue, 17 Mar 2009, Katie wrote: >
>http://www.medicalnewstoday.com/articles/141591.php
>
>If this works in cardiac patients, why couldn't it be used on patients
>for abdominal adhesions? Any thoughts?
>
>--
>Katie
>


Enter keywords:
Returns per screen: Require all keywords: